Treco Douglas A

Treco Douglas A is listed in filings as Director at CRISPR Therapeutics AG. This profile follows SEC Form 4 activity through Jun 9, 2026, including sale activity and purchase activity. Recent filings connect the profile to CRISPR Therapeutics AG (CRSP) and Inozyme Pharma, Inc. (INZY). The current snapshot covers public activity from Oct 3, 2024 to Jun 9, 2026. Reported amounts are shown as $673.9K to $424.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.